Curative Biotechnology, Inc.
CUBT
$0.0118
$0.00087.27%
| Weiss Ratings | CUBT - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Unrated | |||
| Risk Index | Unrated | |||
| Risk Grade | U | |||
| Reward Grade | U | |||
| Rating Factors | CUBT - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | Unrated | |||
| Growth Index | Unrated | |||
| Efficiency Index | Unrated | |||
| Solvency Index | Unrated | |||
| Total Return Index | Unrated | |||
| Volatility Index | Unrated | |||
| Beta / Standard Deviation | CUBT - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.44 | |||
| Price History | CUBT - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -21.33% | |||
| 30-Day Total Return | -4.84% | |||
| 60-Day Total Return | -14.49% | |||
| 90-Day Total Return | 49.37% | |||
| Year to Date Total Return | -12.59% | |||
| 1-Year Total Return | -57.09% | |||
| 2-Year Total Return | -43.27% | |||
| 3-Year Total Return | -75.05% | |||
| 5-Year Total Return | -30.59% | |||
| 52-Week High % Change | -65.62% | |||
| 52-Week Low % Change | 746.15% | |||
| Price | CUBT - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.03 | |||
| 52-Week Low Price | $0.00 | |||
| 52-Week Low Price (Date) | Sep 03, 2024 | |||
| 52-Week High Price (Date) | Apr 19, 2024 | |||
| Valuation | CUBT - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 10.11M | |||
| Enterprise Value | 12.32M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.03 | |||
| Earnings Per Share Growth | -41.52% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | -- | |||
| Price/Book (Q) | -- | |||
| Enterprise Value/Revenue (TTM) | -- | |||
| Price | $0.01 | |||
| Enterprise Value/EBITDA (TTM) | -2.89 | |||
| Enterprise Value/EBIT | -2.89 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | CUBT - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 571.65M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | CUBT - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 561 907 8990 | |||
| Address | 3801 PGA Blvd Palm Beach Gardens, FL 33410 | |||
| Website | curativebiotech.com | |||
| Country | United States | |||
| Year Founded | -- | |||
| Profitability | CUBT - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -- | |||
| Profit Margin | -- | |||
| Management Effectiveness | CUBT - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -179.94% | |||
| Return on Equity | -- | |||
| Income Statement | CUBT - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | -- | |||
| Total Revenue (TTM) | -- | |||
| Revenue Per Share | -- | |||
| Gross Profit (TTM) | -- | |||
| EBITDA (TTM) | -4.26M | |||
| EBIT (TTM) | -4.27M | |||
| Net Income (TTM) | -5.04M | |||
| Net Income Avl. to Common (TTM) | -5.04M | |||
| Total Revenue Growth (Q YOY) | -- | |||
| Earnings Growth (Q YOY) | -39.65% | |||
| EPS Diluted (TTM) | -0.03 | |||
| EPS Diluted Growth (Q YOY) | 8.00% | |||
| Balance Sheet | CUBT - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 600.00 | |||
| Cash Per Share (Q) | $0.00 | |||
| Total Current Assets (Q) | 24.40K | |||
| Total Preferred Equity (Q) | 18.07 | |||
| Total Equity (Q) | -1.05M | |||
| Current Ratio (Q) | 0.008 | |||
| Book Value Per Share (Q) | -- | |||
| Total Assets (Q) | 2.01M | |||
| Total Current Liabilities (Q) | 3.06M | |||
| Total Debt (Q) | 846.50K | |||
| Total Liabilities (Q) | 3.06M | |||
| Total Common Equity (Q) | -19.12M | |||
| Cash Flow | CUBT - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -83.80K | |||
| Cash from Financing (TTM) | 1.60M | |||
| Net Change in Cash (TTM) | -731.20K | |||
| Levered Free Cash Flow (TTM) | -193.10K | |||
| Cash from Operations (TTM) | -2.25M | |||
